Macular Degeneration

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

The following article was originally published in the Hadassah International 2022 Year In Review. To access the complete Hadassah International 2022 Year in Review – click here: Cure. Innovation. Humanity. “For…

Hadassah Ophthlamology Department Research Highlighted by JAMA

Hadassah France

Save The Date: Hadassah France Gala Thursday, May 24, 2018. An Evening With George Gershwin

Macular Degeneration

Safety Success in Hadassah AMD Stem Cell Trial to be Presented at International Conference

Macular Degeneration

Successful Start to Hadassah’s Unique Stem Cell Clinical Trial to Treat Major Cause of Blindness

Macular Degeneration

First Patient Receives Stem Cell-based Therapy for Macular Degeneration at Hadassah

Macular Degeneration

Clinical Trials for Macular Degeneration start as Cell Cure Receives Major Grant to Further Develop Unique Treatment for AMD

Macular Degeneration

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

Macular Degeneration

Cell Cure Neurosciences Receives Grant of $1.33 Million From Israel’s Office of the Chief Scientist

Macular Degeneration

New Investment Platform Created for Hadasit Bio-Holdings in United States

ALS Research

Today’s Research is Tomorrow’s Therapy

Macular Degeneration

Hadassah-Generated Stem Cell Treatment for Macular Degeneration to be Developed and Commercialized

Genetics

Hadassah Medical Center Researchers Zero In On Hereditary Retinal Degeneration

Macular Degeneration

Hadassah International

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

Hadassah Ophthlamology Department Research Highlighted by JAMA

Save The Date: Hadassah France Gala Thursday, May 24, 2018. An Evening With George Gershwin

Safety Success in Hadassah AMD Stem Cell Trial to be Presented at International Conference

Successful Start to Hadassah’s Unique Stem Cell Clinical Trial to Treat Major Cause of Blindness

First Patient Receives Stem Cell-based Therapy for Macular Degeneration at Hadassah

Hadassah University Hospital is currently recruiting patients with the retinal disease

Clinical Trials for Macular Degeneration start as Cell Cure Receives Major Grant to Further Develop Unique Treatment for AMD

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

Cell Cure Neurosciences Receives Grant of $1.33 Million From Israel’s Office of the Chief Scientist

New Investment Platform Created for Hadasit Bio-Holdings in United States

Today’s Research is Tomorrow’s Therapy

Hadassah-Generated Stem Cell Treatment for Macular Degeneration to be Developed and Commercialized

Hadassah Medical Center Researchers Zero In On Hereditary Retinal Degeneration

Hope For Macular Degeneration